TXN Stock Analysis: Texas Instruments | NASDAQ
Semiconductors | NASDAQ, USA | Market Cap: 253.576m USD | 12M Return: 91.2% | US8825081040 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.62B
EPS Trend: 20.1%
Qual. Beats: 3
Rev. Trend: 73.0%
Qual. Beats: 3
Warnings
No concerns identified
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Texas Instruments Incorporated (TXN) is a U.S.-based semiconductor company that designs, manufactures, and sells chips to electronics designers and manufacturers worldwide, with operations spanning the United States, China, the rest of Asia, Europe, the Middle East, Africa, and Japan. The company runs two reporting segments: Analog, which supplies power management and signal chain components such as battery management solutions, DC/DC regulators, amplifiers, data converters, and sensors; and Embedded Processing, which offers microcontrollers, processors, wireless connectivity, and radar products. Beyond these core segments, TXN also produces DLP projection technology, calculators, and application-specific integrated circuits (ASICs), and serves end markets including industrial, automotive, personal electronics, communications equipment, and enterprise systems. Products are sold through direct sales, distributors, and the companys website. The firm was founded in 1930 and is headquartered in Dallas, Texas, and has been listed on the NASDAQ since 1953.
The analog semiconductor segment is the companys primary revenue driver, and analog chips are generally characterized by long product lifecycles and customer-specific customization, which supports stable, recurring design-in revenue across the industrial and automotive end markets. Texas Instruments operates its own internal wafer fabrication facilities, a capital-intensive model that differentiates it from many fabless competitors and gives it greater control over supply and manufacturing costs.
- Industrial weakness pressures Analog segment margins and factory utilization rates
- 300mm fab expansion lifts spending, pressures near-term free cash flow
- China revenue concentration faces escalating US semiconductor export controls
| Net Income: 7.11b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA 13.92 > 1.0 |
| NWC/Revenue: 66.76% < 20% (prev 62.31%; Δ 4.45% < -1%) |
| CFO/TA 0.27 > 3% & CFO 9.90b > Net Income 7.11b |
| Net Debt (6.09b) to EBITDA (11.0b): 0.56 < 3 |
| Current Ratio: 5.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (921.0m) vs 12m ago 0.77% < -2% |
| Gross Margin: 60.24% > 18% (prev 57.48%; Δ 2.76% > 0.5%) |
| Asset Turnover: 57.81% > 50% (prev 49.33%; Δ 8.48% > 0%) |
| Interest Coverage Ratio: 15.41 > 6 (EBIT TTM 8.69b / Interest Expense TTM 564.0m) |
| A: 0.38 (Total Current Assets 16.9b - Total Current Liabilities 3.02b) / Total Assets 36.8b |
| B: 1.47 (Retained Earnings 54.3b / Total Assets 36.8b) |
| C: 0.24 (EBIT TTM 8.69b / Avg Total Assets 35.9b) |
| D: 1.09 (Book Value of Equity 19.2b / Total Liabilities 17.7b) |
| Altman-Z'' = 10.04 = AAA |
| DSRI: 1.06 (Receivables 2.62b/2.06b, Revenue 20.8b/17.3b) |
| GMI: 0.95 (GM 57.48% / 60.24%) |
| AQI: 0.88 (AQ_t 0.22 / AQ_t-1 0.25) |
| SGI: 1.20 (Revenue 20.8b / 17.3b) |
| TATA: -0.08 (NI 7.11b - CFO 9.90b) / TA 36.8b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of November 11, 2026, the stock is trading at USD 300.52 with a total of 6,120,525 shares traded. Over the past week, the price has changed by -3.83%, over one month by +7.19%, over three months by +7.68% and over the past year by +91.22%.
Current recommended Stop Loss: 281.40 (which is 6.4% or 1.5 ATR below the current price).
Texas Instruments has received a consensus analysts rating of 3.97. Therefore, it is recommended to buy TXN.
- StrongBuy: 18
- Buy: 2
- Hold: 13
- Sell: 0
- StrongSell: 2
| Analysts Target Price | 336.9 | 12.1% |
P/E Trailing = 35.9741
P/E Forward = 24.3902
P/S = 12.2111
P/B = 13.2174
P/EG = 0.8408
Revenue TTM = 20.8b USD
EBIT TTM = 8.69b USD
EBITDA TTM = 11.0b USD
Long Term Debt = 12.9b USD (from longTermDebt, last quarter)
Short Term Debt = 650.0m USD (from shortTermDebt, last quarter)
Debt = 14.2b USD (from shortLongTermDebtTotal, last quarter) + Leases 681.0m
Net Debt = 6.09b USD (calculated: Debt 14.2b - CCE 8.14b)
Enterprise Value = 260b USD (254b + Debt 14.2b - CCE 8.14b)
Interest Coverage Ratio = 15.41 (Ebit TTM 8.69b / Interest Expense TTM 564.0m)
EV/FCF = 35.48x (Enterprise Value 260b / FCF TTM 7.32b)
FCF Yield = 2.82% (FCF TTM 7.32b / Enterprise Value 260b)
FCF Margin = 35.24% (FCF TTM 7.32b / Revenue TTM 20.8b)
Net Margin = 34.25% (Net Income TTM 7.11b / Revenue TTM 20.8b)
Gross Margin = 60.24% ((Revenue TTM 20.8b - Cost of Revenue TTM 8.26b) / Revenue TTM)
Gross Margin QoQ = 64.19% (prev 61.36%)
Tobins Q-Ratio = 7.05 (Enterprise Value 260b / Total Assets 36.8b)
Interest Expense / Debt = 3.96% (Interest Expense 564.0m / Debt 14.2b)
Taxrate = 12.50% (1.02b / 8.13b)
NOPAT = 7.61b (EBIT 8.69b * (1 - 12.50%))
Current Ratio = 5.59 (Total Current Assets 16.9b / Total Current Liabilities 3.02b)
Debt / Equity = 0.74 (Debt 14.2b / totalStockholderEquity, last quarter 19.2b)
Debt / EBITDA = 0.56 (Net Debt 6.09b / EBITDA 11.0b)
Debt / FCF = 0.83 (Net Debt 6.09b / FCF TTM 7.32b)
Total Stockholder Equity = 17.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.80% (Net Income 7.11b / Total Assets 36.8b)
RoE = 40.51% (Net Income TTM 7.11b / Total Stockholder Equity 17.6b)
RoCE = 28.53% (EBIT 8.69b / Capital Employed (Equity 17.6b + L.T.Debt 12.9b))
RoIC = 22.75% (NOPAT 7.61b / Invested Capital 33.4b)
WACC = 10.36% (E(254b)/V(268b) * Re(10.75%) + D(14.2b)/V(268b) * Rd(3.96%) * (1-Tc(0.12)))
Discount Rate = 10.75% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -7.65 | Cagr: 0.10%
[DCF] Terminal Value 71.74% ; FCFF base≈5.22b ; Y1≈5.99b ; Y5≈8.81b
[DCF] Fair Price = 100.3 (EV 97.8b - Net Debt 6.09b = Equity 91.7b / Shares 914.2m; r=10.36% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 20.06 | EPS CAGR: 2.96% | SUE: 1.95 | # QB: 3
Revenue Correlation: 72.97 | Revenue CAGR: 7.35% | SUE: 1.27 | # QB: 3
EPS current Quarter (2027-03-31): EPS=2.62 | Chg30d=+15.65% | Revisions=+88% | Analysts=22
EPS current Year (2026-12-31): EPS=9.06 | Chg30d=+6.49% | Revisions=+88% | GrowthEPS=+66.2% | GrowthRev=+26.7%
EPS next Year (2027-12-31): EPS=11.58 | Chg30d=+14.28% | Revisions=+89% | GrowthEPS=+27.9% | GrowthRev=+17.3%
[Analyst] Revisions Ratio: +96% (up=68, down=0)